NIH researchers are seeking adults aged 18 and older with sickle cell disease for a research study evaluating VAS-101 gel, an investigational product containing curcumin, to determine whether it is safe and well-tolerated.
What to Expect
- Investigational gel applied to the skin twice weekly for six weeks
- Routine physical exams
- Vital sign checks (blood pressure and heart rate)
- Standard blood draws
- Test to measure oxygen levels and blood flow
- Approximately 14 weeks total, including:
- 4-week screening period
- 10-week study period
- About 15 in-person clinic visits
The NIH Clinical Center is in Bethesda, Maryland, on the Metro Red Line (Medical Center stop).
Learn More and Sign Up
NIH Clinical Center Office of Patient Recruitment
833-JOIN-NIH
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online
Please reference Study # 002508-H
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Heart, Lung and Blood Institute (NHLBI)